The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2019. An outstanding faculty of speakers from the United States and Europe has committed in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development. This meeting is the primary opportunity for oncologists, hematologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care. CO- CHAIRS Alex Adjei, Rochester, USA Román Perez Soler, New York, USA Antoni Ribas, Los Angeles, USA SCIENTIFIC COMMITTEE Alex Adjei, M.D., Ph.D., Mayo Clinic, Rochester, USA Kenneth C. Anderson, M.D., Dana-Farber Cancer Institute Boston, Massachusetts, USA Carlos L. Arteaga, M.D., Harold C. Simmons Cancer Center, Texas, USA Roman Perez Soler, M.D., Albert Einstein College of Medicine, New York, USA Antoni Ribas, M.D., Ph.D., UCLA, Los Angeles, USA Josep Tabernero, M.D., Ph.D., Vall d'Hebron University Hospital, Barcelona, Spain CONFERENCE SECRETARIAT AND INFORMATION E-mail: secretariat@oncologyconferences.com.ar Web: www.oncologyconferences.com.ar